MedTrace Logo

Zero-fluoroscopic Ablation Versus Conventional Fluoroscopic Ablation for the Treatment of Ventricular Arrhythmias

NCT03041519 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2017-02-02

No results posted yet for this study

Summary

This study is intended to compare the feasibility, safety and efficacy of a zero-fluoroscopy approach using Ensite NavX as the only imaging modality with conventional fluoroscopic approach for the catheter ablation of idiopathic ventricular arrhythmias; conventional fluoroscopic approach use fluoroscopy plus Ensite NavX or plus Carto as the imaging modality.

Conditions

  • Ventricular Arrythmia
  • Ventricular Premature Complexes
  • Ventricular Tachycardia

Interventions

PROCEDURE

Zero-fluoroscopy ablation

Catheter ablation will be performed under the guidance of Ensite NavX and without fluoroscopy.

PROCEDURE

Conventional fluoroscopy ablation

Catheter ablation will be performed under the guidance of fluoroscopy pllus Ensite NavX.

Sponsors & Collaborators

  • Fu Wai Hospital, Beijing, China

    collaborator OTHER

  • Xinyang Central Hospital

    collaborator OTHER

  • Ningbo No. 1 Hospital

    collaborator OTHER

  • Shanghai Tongji Hospital, Tongji University School of Medicine

    collaborator OTHER

  • Guangxi Medical University

    collaborator OTHER

  • Tongji Hospital

    lead OTHER

Principal Investigators

  • Yan Wang, PhD · Tongji Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-10-31
Primary Completion
2017-07-31
Completion
2018-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03041519 on ClinicalTrials.gov